FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3039200315> ?p ?o ?g. }

• W3039200315 endingPage "1918" @default.
• W3039200315 startingPage "1917" @default.
• W3039200315 abstract "A recent article by Batlle et al.1 entitled “AKI in COVID-19: Emerging Evidence of a Distinct Pathophysiology” has discussed comprehensively the possible pathophysiology of AKI in novel coronavirus disease 2019 (COVID-19), a complication of COVID-19 that many have largely ignored. Although the authors were right to avoid speculating about specific interventions until a full picture has been obtained, we feel that sound hypotheses with evidence extrapolated from the COVID-19 population may help in the design of clinical trials or even prospective studies to better understand what works and what does not, since in the field of medicine it is always about testing hypotheses (without causing harm), especially amid this COVID-19 pandemic where many lives have been claimed due to complications in such a short period of time. It has now been established that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen for COVID-19, gains entry into host cells through an angiotensin-converting enzyme 2 (ACE2) protein, which is also abundantly expressed in the kidney. Authors have speculated about direct viral infection of the kidney, where SARS-CoV-2 gains entry through the ACE2 protein of the proximal tubule. In this sense, the use of renin-angiotensin system (RAS) inhibitors, including ACE inhibitors (ACEIs) or angiotensin receptor blockers (ARBs), may be protective toward kidney injury. Firstly, ARBs could compete with SARS-CoV-2 for ACE2-expressing proximal tubular cells, block the binding, and hence the attachment of SARS-CoV-2 to ACE2, thereby inhibiting its entry into the cells. In this way, there may be less entry, if not entirely of no entry, of SARS-CoV-2 into proximal tubular cells. Thus, the proximal tubular cells at risk may be limited, and tubular function of the kidney may be better preserved. Secondly, downregulation of ACE2 upon viral invasion and subsequent increased production of angiotensin II seems to drive the occurrence of kidney injury.2 Both ACE inhibitors and ARBs could block the physiologic effect of angiotensin II. The protective ability of RAS inhibitors may have been hinted in a prospective cohort study of 701 patients with COVID-19. Cheng et al.3 investigated the association between in-hospital medications (on admission and during hospitalization) and the development of AKI among patients with COVID-19. It was noted that none of the patients who were taking RAS inhibitors on admission or during hospitalization for COVID-19 developed AKI. In contrast, almost all patients with COVID-19 who had AKI were receiving antibiotics (35/36; 97%), a well known causative agent for AKI.4 Disclosures All authors have nothing to disclose. Funding None." @default.
• W3039200315 created "2020-07-10" @default.
• W3039200315 creator A5070482896 @default.
• W3039200315 creator A5076366979 @default.
• W3039200315 date "2020-07-01" @default.
• W3039200315 modified "2023-09-27" @default.
• W3039200315 title "Possible Protective Effect of Renin-Angiotensin System Inhibitors in COVID-19 Induced Acute Kidney Injury" @default.
• W3039200315 cites W2904526150 @default.
• W3039200315 cites W3011605790 @default.
• W3039200315 doi "https://doi.org/10.1681/asn.2020050640" @default.
• W3039200315 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7460913" @default.
• W3039200315 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32639940" @default.
• W3039200315 hasPublicationYear "2020" @default.
• W3039200315 type Work @default.
• W3039200315 sameAs 3039200315 @default.
• W3039200315 citedByCount "5" @default.
• W3039200315 countsByYear W30392003152020 @default.
• W3039200315 countsByYear W30392003152021 @default.
• W3039200315 countsByYear W30392003152022 @default.
• W3039200315 crossrefType "journal-article" @default.
• W3039200315 hasAuthorship W3039200315A5070482896 @default.
• W3039200315 hasAuthorship W3039200315A5076366979 @default.
• W3039200315 hasBestOaLocation W30392003152 @default.
• W3039200315 hasConcept C10162356 @default.
• W3039200315 hasConcept C126322002 @default.
• W3039200315 hasConcept C177713679 @default.
• W3039200315 hasConcept C198710026 @default.
• W3039200315 hasConcept C203014093 @default.
• W3039200315 hasConcept C2775946041 @default.
• W3039200315 hasConcept C2778653478 @default.
• W3039200315 hasConcept C2779134260 @default.
• W3039200315 hasConcept C2780091579 @default.
• W3039200315 hasConcept C2780472472 @default.
• W3039200315 hasConcept C2908647359 @default.
• W3039200315 hasConcept C3007834351 @default.
• W3039200315 hasConcept C3008058167 @default.
• W3039200315 hasConcept C524204448 @default.
• W3039200315 hasConcept C71924100 @default.
• W3039200315 hasConcept C84393581 @default.
• W3039200315 hasConcept C99454951 @default.
• W3039200315 hasConceptScore W3039200315C10162356 @default.
• W3039200315 hasConceptScore W3039200315C126322002 @default.
• W3039200315 hasConceptScore W3039200315C177713679 @default.
• W3039200315 hasConceptScore W3039200315C198710026 @default.
• W3039200315 hasConceptScore W3039200315C203014093 @default.
• W3039200315 hasConceptScore W3039200315C2775946041 @default.
• W3039200315 hasConceptScore W3039200315C2778653478 @default.
• W3039200315 hasConceptScore W3039200315C2779134260 @default.
• W3039200315 hasConceptScore W3039200315C2780091579 @default.
• W3039200315 hasConceptScore W3039200315C2780472472 @default.
• W3039200315 hasConceptScore W3039200315C2908647359 @default.
• W3039200315 hasConceptScore W3039200315C3007834351 @default.
• W3039200315 hasConceptScore W3039200315C3008058167 @default.
• W3039200315 hasConceptScore W3039200315C524204448 @default.
• W3039200315 hasConceptScore W3039200315C71924100 @default.
• W3039200315 hasConceptScore W3039200315C84393581 @default.
• W3039200315 hasConceptScore W3039200315C99454951 @default.
• W3039200315 hasIssue "8" @default.
• W3039200315 hasLocation W30392003151 @default.
• W3039200315 hasLocation W30392003152 @default.
• W3039200315 hasOpenAccess W3039200315 @default.
• W3039200315 hasPrimaryLocation W30392003151 @default.
• W3039200315 hasRelatedWork W1974538653 @default.
• W3039200315 hasRelatedWork W2789107158 @default.
• W3039200315 hasRelatedWork W3120579756 @default.
• W3039200315 hasRelatedWork W3123050808 @default.
• W3039200315 hasRelatedWork W3135456873 @default.
• W3039200315 hasRelatedWork W3155094738 @default.
• W3039200315 hasRelatedWork W3176757098 @default.
• W3039200315 hasRelatedWork W4226172547 @default.
• W3039200315 hasRelatedWork W4384501329 @default.
• W3039200315 hasRelatedWork W4213383211 @default.
• W3039200315 hasVolume "31" @default.
• W3039200315 isParatext "false" @default.
• W3039200315 isRetracted "false" @default.
• W3039200315 magId "3039200315" @default.
• W3039200315 workType "article" @default.